Harry Stylli
Founder presso Immunis.AI, Inc.
Profilo
Harry Stylli was the founder of Biora Therapeutics, Inc. (2010), where he held the titles of Chairman & Chief Executive Officer until 2021.
He is also the founder of Immunis.
AI, Inc. Dr. Stylli's current jobs include Executive Chairman at OncoCell MDx, Inc. (since 2019) and Director at Duke Institute For Brain Sciences.
Dr. Stylli's former jobs include President & Chief Executive Officer at Sequenom, Inc. (2005-2009), President & Chief Executive Officer at Xencor, Inc. (2004-2005), President & Chief Executive Officer at CovX Research LLC (2002-2003), Director at Molecular Insight Pharmaceuticals, Inc. (2004-2010), Director at Micropharma Ltd., and President at Aurora Biosciences Corp.
(1995-2002) and Pan Vera LLC (1995).
Dr. Stylli's education includes a doctorate from the University of London, an MBA from The Open University, and an undergraduate degree from the University of East London.
Posizioni attive di Harry Stylli
| Società | Posizione | Inizio |
|---|---|---|
| Duke Institute For Brain Sciences | Director/Board Member | - |
OncoCell MDx, Inc
 OncoCell MDx, Inc BiotechnologyHealth Technology OncoCell MDx, Inc is an American company that focuses on developing and commercializing immunogenic therapies. | Chairman | 01/04/2019 |
Immunis.AI, Inc.
 Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis. | Founder | - |
Precedenti posizioni note di Harry Stylli
| Società | Posizione | Fine |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Chief Executive Officer | 01/09/2021 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Director/Board Member | 12/05/2010 |
| SEQUENOM, INC. | Chief Executive Officer | 28/09/2009 |
| XENCOR, INC. | President | 01/02/2005 |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a private company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | President | 01/07/2003 |
Formazione di Harry Stylli
| University of London | Doctorate Degree |
| The Open University | Masters Business Admin |
| University of East London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| XENCOR, INC. | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Aziende private | 9 |
|---|---|
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Micropharma Ltd.
 Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Micropharma Ltd. formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products. The company was founded by Satya Prakash in 2002 and is headquartered in North Vancouver, Canada. | Health Technology |
Pan Vera LLC
 Pan Vera LLC BiotechnologyHealth Technology PanVera LLC develops protein drug targets and drug screening assays for high throughput screening. The company is headquartered in Madison, WI. | Health Technology |
CovX Research LLC
CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a private company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Health Technology |
OncoCell MDx, Inc
OncoCell MDx, Inc BiotechnologyHealth Technology OncoCell MDx, Inc is an American company that focuses on developing and commercializing immunogenic therapies. | Health Technology |
| Duke Institute For Brain Sciences | |
Immunis.AI, Inc.
Immunis.AI, Inc. Packaged SoftwareTechnology Services Immunis.AI, Inc. develops a non-invasive blood-based immunogenomic platform. The company is based in Royal Oak, MI. The company was founded by Geoffrey R. Erickson, Harry Stylli, Amin I. Kassis. | Technology Services |
- Borsa valori
- Insiders
- Harry Stylli
